Akums Drugs and Pharmaceuticals Limited (NSE:AKUMS)
India · Delayed Price · Currency is INR 657.40
-3.20 (-0.48%)
Jul 31, 2026, 3:29 PM IST
NSE:AKUMS Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, NSE:AKUMS stock has a consensus rating of "Strong Buy" and an average price target of ₹689.36. The average 1-year stock price forecast is 4.86% higher than the current stock price, while the lowest is ₹608.09 (-7.50%) and the highest is ₹780.00 (+18.65%).
Price Target: ₹689.36 (+4.86%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Feb 18, 2026.
Analyst Ratings
The average analyst rating for NSE:AKUMS stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst ICICI Securities No rating | ICICI Securities | Buy Maintains ₹680.00 | Buy | Maintains | ₹680.00 | +3.44% | Feb 18, 2026 |
Financial Forecast
Revenue This Year
48.87B
from 43.61B
Increased by 12.04%
Revenue Next Year
56.45B
from 48.87B
Increased by 15.51%
EPS This Year
24.20
from 17.55
Increased by 37.91%
EPS Next Year
31.46
from 24.20
Increased by 29.98%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.